Subcostal TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Donor Nephrectomy Patients: A Prospective Study
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is whether one local anesthetic, liposomal bupivacaine,
provides improved pain control and decreased opioid use compared to bupivacaine when injected
during a transversus abdominis plane block for donor nephrectomy patients.
Phase:
Phase 4
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute